---

• n  a deficiency of some cellular element of the blood

News & Articles

---

• BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
  JERUSALEM, Aug. 5, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, announced today that BL-8040 has been shown in pre-clinical trials to be effective for the treatment of thrombocytopenia, or reduced platelet production. (Logo:...
  Aug. 5, 2013 - PR Newswire